Your browser doesn't support javascript.
loading
Azacitidine, lenalidomide and donor lymphocyte infusions for relapse of myelodysplastic syndrome, acute myeloid leukemia and chronic myelomonocytic leukemia after allogeneic transplant: the Azalena-Trial.
Schroeder, Thomas; Stelljes, Matthias; Christopeit, Maximilian; Esseling, Eva; Scheid, Christoph; Mikesch, Jan-Henrik; Rautenberg, Christina; Jäger, Paul; Cadeddu, Ron-Patrick; Drusenheimer, Nadja; Holtick, Udo; Klein, Stefan; Trenschel, Rudolf; Haas, Rainer; Germing, Ulrich; Kröger, Nicolaus; Kobbe, Guido.
Afiliação
  • Schroeder T; Department of Hematology and Stem Cell Transplantation, West German Cancer Center Essen, University Hospital Essen, Essen, Germany; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Medical Faculty, Heinrich Heine - University, Duesseldorf. Thomas.Schroeder
  • Stelljes M; Department of Medicine A, Hematology and Oncology, University of Muenster, Muenster.
  • Christopeit M; University Hospital Hamburg-Eppendorf, Clinic for Stem Cell Transplantation, Hamburg.
  • Esseling E; Department of Medicine A, Hematology and Oncology, University of Muenster, Muenster.
  • Scheid C; Department I of Internal Medicine, Medical Faculty and University Hospital, University of Cologne, Cologne.
  • Mikesch JH; Department of Medicine A, Hematology and Oncology, University of Muenster, Muenster.
  • Rautenberg C; Department of Hematology and Stem Cell Transplantation, West German Cancer Center Essen, University Hospital Essen, Essen.
  • Jäger P; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Medical Faculty, Heinrich Heine - University, Duesseldorf.
  • Cadeddu RP; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Medical Faculty, Heinrich Heine - University, Duesseldorf.
  • Drusenheimer N; Coordination Center for Clinical Trials, University Hospital Duesseldorf, Medical Faculty, Heinrich Heine - University, Duesseldorf.
  • Holtick U; Department I of Internal Medicine, Medical Faculty and University Hospital, University of Cologne, Cologne.
  • Klein S; Department of Hematology and Oncology, University Hospital Mannheim, Mannheim.
  • Trenschel R; Department of Hematology and Stem Cell Transplantation, West German Cancer Center Essen, University Hospital Essen, Essen.
  • Haas R; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Medical Faculty, Heinrich Heine - University, Duesseldorf.
  • Germing U; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Medical Faculty, Heinrich Heine - University, Duesseldorf.
  • Kröger N; University Hospital Hamburg-Eppendorf, Clinic for Stem Cell Transplantation, Hamburg.
  • Kobbe G; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Medical Faculty, Heinrich Heine - University, Duesseldorf.
Haematologica ; 108(11): 3001-3010, 2023 11 01.
Article em En | MEDLINE | ID: mdl-37259567
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Leucemia Mielomonocítica Crônica / Leucemia Mieloide Aguda / Transplante de Células-Tronco Hematopoéticas / Doença Enxerto-Hospedeiro Limite: Adult / Humans Idioma: En Revista: Haematologica Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Leucemia Mielomonocítica Crônica / Leucemia Mieloide Aguda / Transplante de Células-Tronco Hematopoéticas / Doença Enxerto-Hospedeiro Limite: Adult / Humans Idioma: En Revista: Haematologica Ano de publicação: 2023 Tipo de documento: Article